InsiderTrades

Form 4 for PCVX Vaxcyte, Inc.

Accepted 2024-09-05 00:00:00 ET · period of report 2024-09-03 · accession 0001649094-24-000066 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2024-09-05 2024-09-03 PCVX Wassil Jim COO S - Sale+OE $111.93 -10.0K 209.1K -5% -$1.12M
D 2024-09-05 2024-09-03 PCVX Wassil Jim COO F - Tax $110.15 -5,545 202.0K -3% -$610.8K
D 2024-09-05 2024-09-03 PCVX Wassil Jim COO M - OptEx $2.42 +10.0K 217.5K +5% +$24.2K
D 2024-09-05 2024-09-03 PCVX Wassil Jim COO M - OptEx $0.00 -10.0K 52.6K -16% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-09-03 S D 3,102 $111.02 212,071 D — — (F4) The price reported is a weighted-average price. The shares were sold at prices ranging from $110.43 to $111.42. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
2 Common Common Stock 2024-09-03 S D 2,263 $111.85 209,808 D — — (F5) The price reported is a weighted-average price. The shares were sold at prices ranging from $111.48 to $112.41. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
3 Common Common Stock 2024-09-03 S D 367 $112.95 209,441 D — — (F6) The price reported is a weighted-average price. The shares were sold at prices ranging from $112.57 to $113.18. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
4 Common Common Stock 2024-09-03 S D 258 $108.01 217,245 D — — (F2) The price reported is a weighted-average price. The shares were sold at prices ranging from $107.67 to $108.425. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
5 Common Common Stock 2024-09-03 S D 344 $115.15 208,708 D — — (F8) The price reported is a weighted-average price. The shares were sold at prices ranging from $114.97 to $115.75. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
6 Common Common Stock 2024-09-03 S D 1,195 $116.42 207,513 D — — (F9) The price reported is a weighted-average price. The shares were sold at prices ranging from $116.02 to $117.00. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
7 Common Common Stock 2024-09-03 S D 10 $117.03 207,503 D — —
8 Common Common Stock 2024-09-03 F D 5,545 $110.15 201,958 D — — (F10) Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of restricted stock units. No other shares of common stock subject to the restrictions on transfer set forth in a Lock-Up Agreement dated September 4, 2024 were sold by the Reporting Person.
9 Common Common Stock 2024-09-03 M A 10,000 $2.42 217,503 D — —
10 Common Common Stock 2024-09-03 S D 2,072 $110.08 215,173 D — — (F3) The price reported is a weighted-average price. The shares were sold at prices ranging from $109.415 to $110.40. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
11 Common Common Stock 2024-09-03 S D 389 $114.25 209,052 D — — (F7) The price reported is a weighted-average price. The shares were sold at prices ranging from $113.84 to $114.80. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
12 Derivative Stock Option (right to buy) 2024-09-03 M D 10,000 $0.00 52,638 D $2.42 · — to 2029-12-16 10,000 Common Stock (F11) 1/4 of the shares subject to the option vested on December 1, 2020, and 1/48 of the shares vest monthly thereafter.